{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:41:21Z","timestamp":1787636481254,"version":"build-2736575974"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006400","name":"Alnylam Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Systemic amyloidosis comprises a heterogeneous group of rare diseases characterised by extracellular deposition of misfolded protein fibrils, leading to progressive organ dysfunction. Due to the variability in clinical presentation and course, collection of system-specific and longitudinal data is essential for understanding disease progression, treatment response and patient outcomes. At the Amyloidosis Center Charit\u00e9 Berlin (ACCB), a prospective amyloidosis registry has been established to systematically collect clinical, laboratory, imaging and patient-reported data with the aim of improving the characterization of the diseases and facilitating translational research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a single-center prospective registry study that enrols patients diagnosed with systemic amyloidosis. The registry includes demographic data, multidisciplinary clinical phenotyping, biomarkers, biobanking, genetic information, imaging studies, and patient reported outcomes. Here, we describe the standardised protocol for diagnostic workup, baseline and longitudinal data collection, and disease-specific follow-up algorithms. Data will be collected digitally in interoperable data formats to ensure shareability in accordance with GDPR-policies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This registry will serve as a resource for characterizing amyloidosis as a rare disease model in a real-world setting and identifying patterns in disease progression and treatment efficacy. By prospectively collecting high-quality longitudinal data, the study aims to generate insights that can inform clinical decision-making, improve risk stratification and support future intervention studies. In addition, the registry enables collaboration in the discovery of biomarkers and new therapeutic approaches. Ongoing analysis of this cohort will provide a basis for the further development of personalised treatment strategies and the improvement of patient care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>\n                      Ethical approval was given by the local ethic committee. Dissemination of data in publications with different scientific observational and correlational questions is planned.\n                      <jats:bold>Clinical trial registration<\/jats:bold>\n                      : DRKS00032002\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0350084","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:22:41Z","timestamp":1780420961000},"page":"e0350084","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["On the crossroads of interdisciplinary medicine in amyloidosis \u2013 study protocol for a single-center interdisciplinary registry study"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8711-5526","authenticated-orcid":true,"given":"Helena","family":"Pernice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Barzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0941-9084","authenticated-orcid":true,"given":"Jakub","family":"Piwowarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harisa","family":"Muratovic-Colic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Pankow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"von Landenberg-Roberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Bohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Schrezenmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9393-5512","authenticated-orcid":true,"given":"Paul J.","family":"Wetzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas W.","family":"Wieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Fi\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Bl\u00fcthner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Knebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Messroghli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie M.","family":"Werhahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gr\u00f6schel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8095-0254","authenticated-orcid":true,"given":"Anna-Karina B","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shideh","family":"Sch\u00f6nfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Schulz-Menger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Heidecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Nogai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Spethmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6013-0072","authenticated-orcid":true,"given":"Katrin","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"3","key":"pone.0350084.ref001","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/joim.13169","article-title":"Systemic amyloidosis from A (AA) to T (ATTR): a review","volume":"289","author":"E Muchtar","year":"2021","journal-title":"J Intern Med"},{"issue":"1","key":"pone.0350084.ref002","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13023-020-01623-1","article-title":"The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis","volume":"16","author":"M Vera-Llonch","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"pone.0350084.ref003","doi-asserted-by":"crossref","first-page":"17539447231216318","DOI":"10.1177\/17539447231216318","article-title":"The importance of pathways to facilitate early diagnosis and treatment of patients with cardiac amyloidosis","volume":"17","author":"CS Kwok","year":"2023","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"2","key":"pone.0350084.ref004","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s10072-024-07793-1","article-title":"Diagnostic delay in patients with sporadic hereditary transthyretin-mediated amyloidosis","volume":"46","author":"B Antunes","year":"2025","journal-title":"Neurol Sci"},{"issue":"3","key":"pone.0350084.ref005","first-page":"185","article-title":"Establishing Patient Registries for Rare Diseases: Rationale and Challenges","volume":"34","author":"V Boulanger","year":"2020","journal-title":"Pharmaceut Med"},{"issue":"9","key":"pone.0350084.ref006","doi-asserted-by":"crossref","DOI":"10.1002\/humu.22619","article-title":"Online registry for mutations in hereditary amyloidosis including nomenclature recommendations","volume":"35","author":"DM Rowczenio","year":"2014","journal-title":"Hum Mutat"},{"issue":"1","key":"pone.0350084.ref007","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1185\/03007995.2012.754348","article-title":"THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis","volume":"29","author":"T Coelho","year":"2013","journal-title":"Curr Med Res Opin"},{"issue":"170","key":"pone.0350084.ref008","doi-asserted-by":"crossref","DOI":"10.3791\/61971","article-title":"TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients","author":"D Schmidt","year":"2021","journal-title":"J Vis Exp"},{"issue":"3","key":"pone.0350084.ref009","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40265-022-01830-z","article-title":"Diagnosis and treatment of AL amyloidosis","volume":"83","author":"G Palladini","year":"2023","journal-title":"Drugs"},{"key":"pone.0350084.ref010","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00508-020-01781-z","article-title":"Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement","volume":"132","author":"D Bonderman","year":"2020","journal-title":"Wien Klin Wochenschr"},{"issue":"1","key":"pone.0350084.ref011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13506129.2019.1693359","article-title":"Causes of AA amyloidosis: a systematic review","volume":"27","author":"AF Brunger","year":"2020","journal-title":"Amyloid"},{"issue":"2","key":"pone.0350084.ref012","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.kint.2021.09.007","article-title":"A mutation in the SAA1 promoter causes hereditary amyloid A amyloidosis","volume":"101","author":"J Sikora","year":"2022","journal-title":"Kidney Int"},{"issue":"9","key":"pone.0350084.ref013","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/ard-2023-225114","article-title":"bDMARD can prevent the progression of AA amyloidosis to end-stage renal disease","volume":"83","author":"P Kvacskay","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"pone.0350084.ref014","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/CLEP.S39981","article-title":"Systemic AA amyloidosis: epidemiology, diagnosis, and management","volume":"6","author":"D Real de As\u00faa","year":"2014","journal-title":"Clin Epidemiol"},{"key":"pone.0350084.ref015","doi-asserted-by":"crossref","unstructured":"Lachmann HJ, Goodman HJB, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, et al. Natural History and Outcome in Systemic AA Amyloidosis. New England Journal of Medicine. 2007;356(23):2361\u201371.","DOI":"10.1056\/NEJMoa070265"},{"issue":"20","key":"pone.0350084.ref016","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1182\/bloodadvances.2023010324","article-title":"Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis","volume":"7","author":"JN Gustine","year":"2023","journal-title":"Blood Adv"},{"issue":"2","key":"pone.0350084.ref017","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/13506129.2020.1713081","article-title":"Involvement of small nerve fibres and autonomic nervous system in AL amyloidosis: comprehensive characteristics and clinical implications","volume":"27","author":"P Kokotis","year":"2020","journal-title":"Amyloid"},{"issue":"4","key":"pone.0350084.ref018","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1468-1331.2010.03215.x","article-title":"Peripheral nerve involvement in primary systemic AL amyloidosis: a clinical and electrophysiological study","volume":"18","author":"M Matsuda","year":"2011","journal-title":"Eur J Neurol"},{"issue":"6","key":"pone.0350084.ref019","doi-asserted-by":"crossref","DOI":"10.3390\/jcm13061744","article-title":"Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management","volume":"13","author":"A Shafqat","year":"2024","journal-title":"J Clin Med"},{"key":"pone.0350084.ref020","first-page":"4","article-title":"Gastroduodenal involvement in AL amyloidosis: case report and literature review","volume":"12","author":"R Ramachandran","year":"2024","journal-title":"J Investig Med High Impact Case Rep"},{"key":"pone.0350084.ref021","doi-asserted-by":"crossref","DOI":"10.2196\/58445","article-title":"State-of-the-art fast healthcare interoperability resources (fhir)-based data model and structure implementations: systematic scoping review","volume":"12","author":"P Tabari","year":"2024","journal-title":"JMIR Med Inform"},{"key":"pone.0350084.ref022","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkad1005","article-title":"The Human Phenotype Ontology in 2024: phenotypes around the world","volume":"52","author":"MA Gargano","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"pone.0350084.ref023","article-title":"Access to and use of data for better healthcare: a plea for a cooperative data and research infrastructure of statutory and private health insurers and the network university medicine (NUM)","author":"J Schmitt","year":"2024","journal-title":"Gesundheitswesen"},{"key":"pone.0350084.ref024","first-page":"307","article-title":"Towards a national portal for medical research data (FDPG): vision, status, and lessons learned","volume":"302","author":"HU Prokosch","year":"2023","journal-title":"Stud Health Technol Inform"},{"issue":"1","key":"pone.0350084.ref025","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s13023-022-02558-5","article-title":"Towards FAIRification of sensitive and fragmented rare disease patient data: challenges and solutions in European reference network registries","volume":"17","author":"B Dos Santos Vieira","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"pone.0350084.ref026","doi-asserted-by":"crossref","first-page":"832063","DOI":"10.3389\/fendo.2022.832063","article-title":"Rare Disease Registries Are Key to Evidence-Based Personalized Medicine: Highlighting the European Experience","volume":"13","author":"S K\u00f6lker","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"pone.0350084.ref027","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1185\/03007995.2012.754349","article-title":"The Transthyretin Amyloidosis Outcomes Survey (THAOS) registry: design and methodology","volume":"29","author":"V Plant\u00e9-Bordeneuve","year":"2013","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"pone.0350084.ref028","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13023-023-02962-5","article-title":"A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"18","author":"L Gentile","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"pone.0350084.ref029","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cardfail.2023.09.016","article-title":"The Cardiac Amyloidosis Registry Study (CARS): Rationale, Design and Methodology","volume":"30","author":"LK Stern","year":"2024","journal-title":"J Card Fail"},{"issue":"5","key":"pone.0350084.ref030","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.cardfail.2023.12.016","article-title":"With Great Data Come Great Responsibilities: The Cardiac Amyloidosis Registry Study","volume":"30","author":"J Maning","year":"2024","journal-title":"J Card Fail"},{"issue":"1","key":"pone.0350084.ref031","doi-asserted-by":"crossref","DOI":"10.1016\/j.acvd.2024.10.009","article-title":"The Healthcare Amyloidosis European Registry (HEAR): Study design and methods","volume":"118","author":"P R\u00e9ant","year":"2025","journal-title":"Archives of Cardiovascular Diseases"},{"issue":"2","key":"pone.0350084.ref032","first-page":"86","article-title":"Registry of Transthyretin Amyloidosis in the State of S\u00e3o Paulo (REACT-SP)","volume":"1","author":"F Fernandes","year":"2021","journal-title":"ABC: Heart Failure & Cardiomyopathy"},{"issue":"1","key":"pone.0350084.ref033","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13023-024-03281-z","article-title":"Clinical and genetic profiles of patients with hereditary and wild-type transthyretin amyloidosis: the Transthyretin Cardiac Amyloidosis Registry in the state of S\u00e3o Paulo, Brazil (REACT-SP)","volume":"19","author":"F Fernandes","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"pone.0350084.ref034","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209743","article-title":"Framework for Multistakeholder Patient Registries in the Field of Rare Diseases: Focus on Neurogenetic Diseases","volume":"103","author":"DH Schoenmakers","year":"2024","journal-title":"Neurology"},{"issue":"6","key":"pone.0350084.ref035","first-page":"656","article-title":"Interoperability Working Group: core dataset and information systems for data integration and data exchange in the Medical Informatics Initiative","volume":"67","author":"D Ammon","year":"2024","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0356916","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000}}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350084","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T17:22:48Z","timestamp":1780420968000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350084"}},"subtitle":[],"editor":[{"given":"Hualin","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0350084","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]}}}